Acadia Pharmaceuticals (ACAD) Current Deferred Revenue (2010 - 2017)
Acadia Pharmaceuticals' Current Deferred Revenue was $4.13 million in Q1 2017, up 56.3% from the prior quarter.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Current Deferred Revenue (2010 - 2017) Analysis & Trends
At the end of FY2016, Current Deferred Revenue at Acadia Pharmaceuticals came in at $2.64 million.
- Current Deferred Revenue shows a five-year compound annual growth rate of 31.6% (FY2011 to FY2016).
- In earlier years, Current Deferred Revenue was $55,000 in FY2013 (-87.3%) and $434,000 in FY2012 (-35.1%).
- The Q1 2017 figure marks the highest quarterly Current Deferred Revenue in data going back to Q4 2010.
- The best year-over-year quarter for Current Deferred Revenue over five years was Q2 2012 (growth of 1.6%); the worst was Q4 2013 (a decline of 87.3%).
- Per Business Quant data, ACAD's Current Deferred Revenue in the three quarters before Q1 2017 was $2.64 million (Q4 2016), $1.88 million (Q3 2016) and $513,000 (Q2 2016).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,168.95 Bn | 1,137.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 642.08 Bn | 560.60 Bn | 17.26 Bn |
| 3 | AbbVie | 500.03 Bn | 473.14 Bn | 12.70 Bn |
| 4 | Merck | 359.04 Bn | 313.42 Bn | 12.21 Bn |
| 5 | Novartis Ag | 301.98 Bn | 265.97 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.05 Bn | 240.74 Bn | 12.86 Bn |
| 7 | Amgen | 241.60 Bn | 197.00 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 192.44 Bn | 166.64 Bn | 6.22 Bn |
| 9 | Pfizer | 171.37 Bn | 118.01 Bn | 10.94 Bn |
| 10 | Acadia Pharmaceuticals | 3.45 Bn | -20.27 Mn | 279.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2017 | 4.13 Mn |
| Dec 31, 2016 | 2.64 Mn |
| Sep 30, 2016 | 1.88 Mn |
| Jun 30, 2016 | 513,000.00 |
| Sep 30, 2014 | 15,000.00 |
| Jun 30, 2014 | 29,000.00 |
| Mar 31, 2014 | 42,000.00 |
| Dec 31, 2013 | 55,000.00 |
| Sep 30, 2013 | 80,000.00 |
| Jun 30, 2013 | 111,000.00 |
| Mar 31, 2013 | 140,000.00 |
| Dec 31, 2012 | 434,000.00 |
| Sep 30, 2012 | 266,000.00 |
| Jun 30, 2012 | 765,000.00 |
| Mar 31, 2012 | 683,000.00 |
| Dec 31, 2011 | 669,000.00 |
| Sep 30, 2011 | 708,000.00 |
| Jun 30, 2011 | 753,000.00 |
| Dec 31, 2010 | 690,000.00 |
API Access
Acadia Pharmaceuticals Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();